Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | Director | June 16, 2026 | June 18, 2026 |
| UpHealth, Inc.UPHL · Entity 88003 | Director | May 21, 2024 | June 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date June 16, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 426,286 |
Reported balance
After 2026-06-16 transaction · row 1
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 73,434 · Balance 426,286 F1: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date.
UpHealth, Inc.
Report date May 21, 2024 · Filed June 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 113,905 |
Reported balance
After 2024-05-21 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2024-05-21 · Sale · Disposed 500 · Balance 113,905 F2: The Reporting Person has voluntarily delivered to the Company the full amount of the disgorgeable profit arising from the sales reported herein, in the amount of $7,714.36. F1: Includes Restricted Stock Units ("Prior RSUs") of UpHealth, Inc. (the "Company"), that are subject to vesting pursuant to previously disclosed vesting schedules. |
| Common StockSEC Table I · non-derivative | Direct | 101,123 |
Reported balance
After 2024-05-21 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2024-05-21 · Sale · Disposed 12,782 · Balance 101,123 F2: The Reporting Person has voluntarily delivered to the Company the full amount of the disgorgeable profit arising from the sales reported herein, in the amount of $7,714.36. F1: Includes Restricted Stock Units ("Prior RSUs") of UpHealth, Inc. (the "Company"), that are subject to vesting pursuant to previously disclosed vesting schedules. |
| Common StockSEC Table I · non-derivative | Direct | 114,405 |
Reported balance
Holding disclosure · report date 2024-05-21 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 114,405 F1: Includes Restricted Stock Units ("Prior RSUs") of UpHealth, Inc. (the "Company"), that are subject to vesting pursuant to previously disclosed vesting schedules. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes Restricted Stock Units ("Prior RSUs") of UpHealth, Inc. (the "Company"), that are subject to vesting pursuant to previously disclosed vesting schedules.
F2: The Reporting Person has voluntarily delivered to the Company the full amount of the disgorgeable profit arising from the sales reported herein, in the amount of $7,714.36.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 18, 2026 00:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 73,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000130 · wk-form4_1781742958.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 426,286 F1 · shares: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 23:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 192,185 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001809519-26-000055 · wk-form4_1773444144.xml · derivative · entry 4 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 192,185 shares Expires 2026-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 23:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 75,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000055 · wk-form4_1773444144.xml · nonDerivative · entry 3 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,852 F1 · shares: On March 12, 2026, the Reporting Person transferred 75,219 shares of Class A common stock to the Agnes Rey-Giruad Trust DTD 09/13/2002 RST 12/10/2012 (the "Trust"). The Reporting Person serves as the sole trustee and sole beneficiary of the Trust. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 23:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 75,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000055 · wk-form4_1773444144.xml · nonDerivative · entry 2 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 0 F1 · shares: On March 12, 2026, the Reporting Person transferred 75,219 shares of Class A common stock to the Agnes Rey-Giruad Trust DTD 09/13/2002 RST 12/10/2012 (the "Trust"). The Reporting Person serves as the sole trustee and sole beneficiary of the Trust. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 23:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 192,185 | $0.47 | $90,326.95 |
DisclosureSEC source: 0001809519-26-000055 · wk-form4_1773444144.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 22:07 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 75,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-040839 · wk-form4_1755641217.xml · nonDerivative · entry 2 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 75,219 F1 · shares: On August 18, 2025, the Reporting Person transferred 75,219 shares of Class A common stock to the ARG Family Legacy Trust #1 (the "Trust"). The Reporting Person serves as the sole trustee of the Trust, and the Reporting Person and other members of her family are the beneficiaries of the Trust. F1 · balance_after: On August 18, 2025, the Reporting Person transferred 75,219 shares of Class A common stock to the ARG Family Legacy Trust #1 (the "Trust"). The Reporting Person serves as the sole trustee of the Trust, and the Reporting Person and other members of her family are the beneficiaries of the Trust. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 22:07 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 75,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-040839 · wk-form4_1755641217.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,448 F1 · shares: On August 18, 2025, the Reporting Person transferred 75,219 shares of Class A common stock to the ARG Family Legacy Trust #1 (the "Trust"). The Reporting Person serves as the sole trustee of the Trust, and the Reporting Person and other members of her family are the beneficiaries of the Trust. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 22:50 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 57,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000092 · wk-form4_1749077440.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,667 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 3, 2025 and (ii) the date of the 2026 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 21:29 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000144 · wk-form4_1720646945.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,617 F1 · shares: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 28,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000112 · wk-form4_1718061112.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,153 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 6, 2024 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2027; (ii) Separation from Service; (iii) a Change in Control; (iv) Death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| May 21, 2024 Filed Jun 7, 2024 23:34 UTC | UpHealth, Inc. UPHL · Entity 88003 | SaleCommon Stock | 12,782 | $0.60 | $7,669.20 |
DisclosureSEC source: 0000950170-24-070998 · ownership.xml · nonDerivative · entry 2 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,123 F2 · kind: The Reporting Person has voluntarily delivered to the Company the full amount of the disgorgeable profit arising from the sales reported herein, in the amount of $7,714.36. F1 · balance_after: Includes Restricted Stock Units ("Prior RSUs") of UpHealth, Inc. (the "Company"), that are subject to vesting pursuant to previously disclosed vesting schedules. Read SEC document |
| May 21, 2024 Filed Jun 7, 2024 23:34 UTC | UpHealth, Inc. UPHL · Entity 88003 | SaleCommon Stock | 500 | $0.61 | $305.00 |
DisclosureSEC source: 0000950170-24-070998 · ownership.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,905 F2 · kind: The Reporting Person has voluntarily delivered to the Company the full amount of the disgorgeable profit arising from the sales reported herein, in the amount of $7,714.36. F1 · balance_after: Includes Restricted Stock Units ("Prior RSUs") of UpHealth, Inc. (the "Company"), that are subject to vesting pursuant to previously disclosed vesting schedules. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 23:23 UTC | UpHealth, Inc. UPHL · Entity 88003 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-001881 · form4.xml · nonDerivative · entry 2 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,405 F2 · shares: Subject to the Reporting Person's continued service to the Company, the Restricted Stock Units ("RSUs") shall vest on January 1, 2025; all RSUs shall immediately vest in the event of a Change of Control (as defined in the UpHealth, Inc. 2021 Equity Incentive Plan) of the Company. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 23:35 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 39,177 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-028430 · ownership.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,755 F1 · shares: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 14, 2023 and (ii) the date of the 2024 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:10 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 27,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-022800 · doc4.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,578 F1 · shares: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 14, 2022 and (ii) the date of the 2023 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. Read SEC document |
| December 28, 2021 Filed Feb 12, 2022 02:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass B Common Stock · Derivative | 28,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-005996 · doc5.xml · derivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 226,500 Underlying: Class A Common Stock · 28,500 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F2 · kind: Represents shares of Class B common stock donated as a gift. No value was received for the gifted shares. F1 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F1 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 22:25 UTC | UpHealth, Inc. UPH · Entity 88003 | GrantCommon Stock | 71,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013525 · form4.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,057 F1 · shares: Subject to the Reporting Person's continued service to the Company, the Restricted Stock Units ("RSUs") shall vest on vest quarterly on each of February 1, May 1, August 1 and November 1, 2022; all RSUs shall immediately vest in the event of a Change of Control (as defined in the UpHealth, Inc. 2021 Equity Incentive Plan) of the Company. Read SEC document |
| September 16, 2021 Filed Sep 16, 2021 23:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 5,909 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036346 · doc4.xml · derivative · entry 9 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 255,000 Underlying: Class A Common Stock · 5,909 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F4 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F4 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 16, 2021 Filed Sep 16, 2021 23:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 5,909 | $45.01 | $265,935.73 |
DisclosureSEC source: 0000899243-21-036346 · doc4.xml · nonDerivative · entry 6 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 16, 2021 Filed Sep 16, 2021 23:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 5,909 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036346 · doc4.xml · nonDerivative · entry 5 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 5,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 23:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 4,637 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036346 · doc4.xml · derivative · entry 8 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 260,909 Underlying: Class A Common Stock · 4,637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F4 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F4 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 23:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 4,637 | $45.03 | $208,796.23 |
DisclosureSEC source: 0000899243-21-036346 · doc4.xml · nonDerivative · entry 4 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.22, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 23:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 4,637 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036346 · doc4.xml · nonDerivative · entry 3 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 4,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 14,454 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036346 · doc4.xml · derivative · entry 7 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 265,546 Underlying: Class A Common Stock · 14,454 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F4 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F4 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 14,454 | $45.00 | $650,461.80 |
DisclosureSEC source: 0000899243-21-036346 · doc4.xml · nonDerivative · entry 2 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:53 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 14,454 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036346 · doc4.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 14,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 20:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 54,370 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-035412 · doc4.xml · derivative · entry 3 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 280,000 Underlying: Class A Common Stock · 54,370 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F2 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F2 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 20:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 54,370 | $41.56 | $2,259,682.44 |
DisclosureSEC source: 0000899243-21-035412 · doc4.xml · nonDerivative · entry 2 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.25 to $41.94, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 20:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 54,370 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-035412 · doc4.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 54,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2021 Filed Aug 17, 2021 01:51 UTC | UpHealth, Inc. UPH · Entity 88003 | GrantCommon Stock | 67,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-007611 · form4.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,327 F1 · shares: Subject to the Reporting Person's continued service to the Company, 1/3 of the Restricted Stock Units ("RSUs") shall vest on May 1, 2022, and the remaining 2/3 of the RSUs shall vest quarterly on each of August 1, November 1, February 1, and May 1 through May 1, 2024; all RSUs shall immediately vest in the event of a Change of Control (as defined in the UpHealth, Inc. 2021 Equity Incentive Plan) of the Company. Read SEC document |
| August 12, 2021 Filed Aug 20, 2021 01:22 UTC Amendment | UpHealth, Inc. UPH · Entity 88003 | GrantCommon Stock | 67,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-007804 · form4a.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,327 F1 · shares: Subject to the Reporting Person's continued service to the Company, 1/3 of the Restricted Stock Units ("RSUs") shall vest on May 1, 2022, and the remaining 2/3 of the RSUs shall vest quarterly on each of August 1, November 1, February 1, and May 1 through May 1, 2024; all RSUs shall immediately vest in the event of a Change of Control (as defined in the UpHealth, Inc. 2021 Equity Incentive Plan) of the Company. F2 · balance_after: Includes an aggregate of 67,327 RSUs, of which 1/3 of the RSUs shall vest on May 1, 2022, and the remaining 2/3 of the RSUs shall vest quarterly on each of August 1, November 1, February 1, and May 1 through May 1, 2024. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 6,138 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-023582 · doc4.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138 F1 · shares: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 10, 2021 and (ii) the date of the 2022 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014857 · doc4.xml · derivative · entry 3 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 334,370 Underlying: Class A Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 25,000 | $40.01 | $1,000,305.00 |
DisclosureSEC source: 0000899243-21-014857 · doc4.xml · nonDerivative · entry 2 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.13, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014857 · doc4.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:34 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-013313 · doc4.xml · derivative · entry 3 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 359,370 Underlying: Class A Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:34 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 25,000 | $36.38 | $909,602.50 |
DisclosureSEC source: 0000899243-21-013313 · doc4.xml · nonDerivative · entry 2 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.86, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:34 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-013313 · doc4.xml · nonDerivative · entry 1 REY-GIRAUD AGNES · CIK 0001235685 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ARG Family Legacy Trust #1 Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.